The Chemours Aktie
11,10
EUR
-1,12
EUR
-9,17
%
12,91
USD
-0,86
USD
-6,21
%
Werbung
The Chemours Aktie Analyse
29.03.18 | The Chemours Outperform | BMO Capital Markets | |
07.08.17 | The Chemours Neutral | UBS AG | |
09.05.16 | The Chemours overweight | Barclays Capital | |
18.09.15 | The Chemours Hold | Argus Research Company | |
18.08.15 | The Chemours Sell | UBS AG |
Werbung
Werbung